Consumer goods manufacturer Kimberly-Clark (KMB) reported a 20% dip in earnings for the third quarter due to significant commodity and currency headwinds. However, the results exceeded analysts’ expectations. The company also confirmed its previous guidance for the full year 2018. Following this, the stock inched up over 2% in the premarket session.
Net income for the quarter fell 20% to $462 million and earnings dropped 19% to $1.29 per share. However, adjusted earnings increased 7% to $1.71 per share.
Changes in foreign currency exchange rates reduced sales by 3% while organic sales increased 1%. Net sales declined 2% to $4.6 billion. Net selling prices and product mix each improved 1%, while volumes slid 1%.
In North America, organic sales declined 1% in consumer products and increased slightly in K-C Professional. Outside North America, organic sales rose 3% in developing and emerging markets and 1% in developed markets.
Sales from Personal Care Segment declined 1% and that from Consumer Tissue Segment decreased 3%. The segments were hurt by changes in currency rates.
In January 2018, Kimberly-Clark initiated the 2018 Global Restructuring Program. The company expects the program will generate annual pre-tax cost savings of $500 million to $550 million by the end of 2021, driven by workforce reductions along with manufacturing supply chain efficiencies.
As part of the program, Kimberly-Clark expects to exit or divest some low-margin businesses that generate about 1% of company net sales. To implement the program, the company expects to incur restructuring charges of $1.35 billion to $1.5 billion by the end of 2020. The restructuring charges for the third quarter of 2018 were $119 million, bringing cumulative charges to $649 million after tax.
Looking ahead into the full year 2018, the company continues to expect organic sales growth of about 1% and adjusted EPS of $6.60 to $6.80, a year-on-year increase of 6% to 9%. Adjusted effective tax rate outlook was lowered to the range of 21% to 22% from the prior forecast at the low end of 23% to 26% range.
Shares of Kimberly-Clark ended Friday’s regular session up 0.69% at $110.23 on the NYSE. The stock has fallen over 8% in the year so far and over 2% in the past year.
Follow our Google News edition to get the latest stock market, earnings and financial news at your fingertips.
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on